INS and Insulin resistance: As TyG has been validated in the literature against the hyperinsulinemic–euglycemic clamp as a marker of insulin resistance [4,6], its reduction reinforces the improvement in the glucose–insulin axis with the AKMP and complements the interpretation of HOMA-IR.